Neosoma Incorporates Wholly-Owned Swiss Subsidiary
Neosoma, Inc., developer of a software medical device platform to help advance brain cancer care and clinical trials, announced the
Neosoma, Inc., developer of a software medical device platform to help advance brain cancer care and clinical trials, announced the
Neosoma, Inc., developer of a software medical device platform to help advance brain cancer care and clinical trials, announced the incorporation of a wholly-owned subsidiary
Artificial intelligence does not change anything about the fundamental nature of sustained competitive advantage when its use is pervasive. Once #AI’s use is ubiquitous, it will transform economies and lift markets as a whole, but it will not uniquely benefit any single company.
This is Tehran. Let that sink in. You are watching a revolution unfold live while the world’s media stays dead silent. Legacy media has become nothing more than a propaganda machine, because what news could possibly be bigger than this?
@FoxNews @CNN https://x.com/Negaarsh/status/2009316202179645805/video/1